Loading…
Dividends declared (per SOCE filings): FY2022 0
General medicine - private practice in დიდუბის რაიონი, ქ. თბილისი. Address: საქართველო, თბილისი, დიდუბის რაიონი, ქუჩა მარჯანიშვილი , N 6.
GCAP internal — Sectors and enrichment.xlsx (2026-06-10)
| Ratio | 2022 | 2023 | 2024 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 97.2% | 91.5% | 92.8% |
| EBITDA Margin | -103.4% | -4.4% | 10.0% |
| EBITDAR | -422 | 442 | 1,370 |
| EBITDAR Margin | -103.4% | 13.5% | 28.8% |
| EBIT Margin | -103.4% | -19.8% | 1.2% |
| Net Profit Margin | -115.3% | -31.2% | -9.4% |
| Operating Expense % of Sales | 200.6% | 95.9% | 82.8% |
| Returns | |||
| Return on Assets (ROA) | -17.7% | -35.9% | -12.3% |
| Return on Equity (ROE) | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | -17.8% | -25.9% | 2.0% |
| Leverage & debt balances | |||
| Debt-to-Assets | 110.8% | 129.6% | 121.2% |
| Debt-to-Equity | -6.24x | -3.43x | -2.92x |
| Debt-to-EBITDA | N/A | N/A | 9.25x |
| Equity-to-Assets | -17.7% | -37.7% | -41.4% |
| Net Debt | 2,834 | 3,576 | 4,374 |
| Cash & Equivalents | 102 | 108 | 11 |
| Total Debt | 2,936 | 3,685 | 4,384 |
| Liquidity & working capital | |||
| Current Ratio | 0.04x | 0.16x | 0.03x |
| Quick Ratio | 0.04x | 0.16x | 0.03x |
| Cash Ratio | 0.03x | 0.03x | 0.00x |
| Total Current Assets | 110 | 614 | 142 |
| Total Current Liabilities | 3,120 | 3,893 | 5,057 |
| Inventory | N/A | N/A | N/A |
| Trade Receivables | 45 | 359 | 1,103 |
| Trade Payables | 139 | 142 | 400 |
| Net Working Capital | -3,010 | -3,279 | -4,915 |
| Net Working Capital % of Revenue | -738.0% | -100.1% | -103.2% |
| Trade Working Capital | -94 | 217 | 704 |
| Trade Working Capital % of Revenue | -23.1% | 6.6% | 14.8% |
| Change in Trade Working Capital | N/A | 311 | 487 |
| Turnover & efficiency | |||
| Inventory Turnover | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A |
| Receivables Turnover | 9.01x | 9.13x | 4.32x |
| Days Sales Outstanding (DSO) | 40.5 | 40.0 | 84.6 |
| Payables Turnover | 0.08x | 1.95x | 0.86x |
| Days Payable Outstanding (DPO) | 4445.2 | 187.4 | 424.5 |
| Cash Conversion Cycle | -4404.7 days | -147.4 days | -339.9 days |
| Asset Turnover | 0.15x | 1.15x | 1.32x |
| Cash flow & dividends | |||
| Operating Cash Flow | 4,242 | 3,941 | 5,190 |
| Free Cash Flow (OCF − Capex proxy) | 4,242 | 3,941 | 5,190 |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 1095.4% |
| Dividends Declared | 0 | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →